Monthly Archives: January 2017

Key Finding Identifies Most Promising Drug for Targeted Clinical Trial

January 24th, 2017|

As reported in Neuro-Oncology Magazine (January 12th, 2017), with leadership from the Dana Farber Cancer Institute’s Dr. Charles Stiles and up and coming researcher, Dr. Sarah Buhrlage, ground-breaking science […]

Read More
Comments Off on Key Finding Identifies Most Promising Drug for Targeted Clinical Trial

Precision Medicine Impacts Pediatric Brain Cancer Treatment

January 19th, 2017|

Precision medicine—in which diagnosis and treatments are keyed to the genetic susceptibilities of individual cancers—has advanced to the point where it can now impact the care of a majority […]

Read More
Comments Off on Precision Medicine Impacts Pediatric Brain Cancer Treatment